glp-1 and lymphedema Lipedema & Lymphedema: Surgical Advances, Therapies, Future Directions Frontiers | Glucagon-like peptide-1 receptor

The SURMOUNT-1 trial reported -22.5% weight reduction at the 15 mg weekly dose across 72 weeks (PMID 35658024)

References [1] BACTERIOSTATIC WATER for injection, USP prescribing information (0.9% / 9 mg/mL or 1.1% / 11 mg/mL benzyl alcohol added as a bacteriostatic preservative, the 1.1% being a 20 mL fill in a 30 mL glass vial

Um das Auftreten unerwnschter Effekte zu minimieren, wird eine langsame, schrittweise Erhhung der Dosierung empfohlen

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are two hormones responsible for the amplification of insulin secretion after nutrient consumption, and they have different actions (11)

10.1016/j.eclnm.2011.07.001 32